These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33182269)

  • 1. A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities.
    Malankhanova T; Suldina L; Grigor'eva E; Medvedev S; Minina J; Morozova K; Kiseleva E; Zakian S; Malakhova A
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33182269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease.
    Alkanli SS; Alkanli N; Ay A; Albeniz I
    Mol Neurobiol; 2023 Mar; 60(3):1486-1498. PubMed ID: 36482283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mono- and Biallelic Inactivation of Huntingtin Gene in Patient-Specific Induced Pluripotent Stem Cells Reveal HTT Roles in Striatal Development and Neuronal Functions.
    Louessard M; Cailleret M; Jarrige M; Bigarreau J; Lenoir S; Dufour N; Rey M; Saudou F; Deglon N; Perrier AL
    J Huntingtons Dis; 2024; 13(1):41-53. PubMed ID: 38427495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.
    Dabrowska M; Ciolak A; Kozlowska E; Fiszer A; Olejniczak M
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
    Xu X; Tay Y; Sim B; Yoon SI; Huang Y; Ooi J; Utami KH; Ziaei A; Ng B; Radulescu C; Low D; Ng AYJ; Loh M; Venkatesh B; Ginhoux F; Augustine GJ; Pouladi MA
    Stem Cell Reports; 2017 Mar; 8(3):619-633. PubMed ID: 28238795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
    Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
    Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
    Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
    Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington's disease.
    Park HJ; Han A; Kim JY; Choi J; Bae HS; Cho GB; Shin H; Shin EJ; Lee KI; Kim S; Lee JY; Song J
    NPJ Regen Med; 2022 Jan; 7(1):8. PubMed ID: 35046408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
    Geater C; Hernandez S; Thompson L; Mattis VB
    Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases.
    Dabrowska M; Juzwa W; Krzyzosiak WJ; Olejniczak M
    Front Neurosci; 2018; 12():75. PubMed ID: 29535594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
    Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
    Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-to-mouse prion-like propagation of mutant huntingtin protein.
    Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J
    Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.
    Zhang N; An MC; Montoro D; Ellerby LM
    PLoS Curr; 2010 Oct; 2():RRN1193. PubMed ID: 21037797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
    Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
    Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.
    Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H
    Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines.
    Niclis JC; Pinar A; Haynes JM; Alsanie W; Jenny R; Dottori M; Cram DS
    Front Cell Neurosci; 2013; 7():37. PubMed ID: 23576953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
    Lu B; Palacino J
    FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington's disease.
    Linville RM; Nerenberg RF; Grifno G; Arevalo D; Guo Z; Searson PC
    Fluids Barriers CNS; 2022 Jun; 19(1):54. PubMed ID: 35773691
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.